Carregant...
Predicting Response to Immunotherapy in Metastatic Renal Cell Carcinoma
SIMPLE SUMMARY: Immunotherapy-based treatment options have become standard of care in metastatic renal cell carcinoma. Despite significant improvement in overall survival with these therapies, the tumors of many patients will eventually progress. This review highlights the ongoing efforts to develop...
Guardat en:
| Publicat a: | Cancers (Basel) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7565517/ https://ncbi.nlm.nih.gov/pubmed/32961934 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12092662 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|